What is the process of platelet-rich plasma (PRP) therapy for treating androgenetic alopecia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Platelet-Rich Plasma (PRP) Process for Androgenetic Alopecia

For androgenetic alopecia, administer PRP as three intradermal scalp injections spaced one month apart (months 0,1, and 2), combined with topical minoxidil 5% twice daily for superior outcomes compared to either treatment alone. 1, 2

Blood Collection and PRP Preparation

  • Draw 9-15 cc of autologous whole blood from the patient using standard venipuncture technique 3, 4
  • Centrifuge the blood using a commercially available PRP kit for approximately 5 minutes to separate platelet concentrate from other blood components 4, 5
  • This yields 2-6 cc of concentrated PRP ready for injection 4, 5
  • Use nonactivated PRP without additional activation steps, as it demonstrates 31% greater increases in hair count and total hair density compared to activated PRP 1, 2, 6

Injection Technique

  • Inject 2-3 cc of PRP intradermally into the affected scalp areas using an insulin syringe or similar fine-gauge needle 4
  • Distribute injections evenly across areas of hair thinning or loss 1
  • The procedure is performed under sterile conditions 3

Treatment Protocol

  • Administer three treatment sessions, each spaced exactly one month apart (at months 0,1, and 2) 1, 7
  • Concurrent topical minoxidil 5% should be applied at 1 mL twice daily throughout the treatment period and beyond 1
  • Maintenance PRP injections every 6 months are required to sustain results 6

Expected Outcomes and Timeline

  • At 2-3 months: Initial improvements in hair density become visible, with a 25% improvement at 2 months predicting sustained response at 6 months 1
  • At 6 months post-treatment: Hair density increases by 1.74 times, hair diameter increases by 14.3 times, and telogen phase hair decreases by 9.3 times 1, 3
  • Terminal to vellus hair ratio improves in 60% of patients 3
  • Patient satisfaction scores average 7.29-7.42 on a 10-point scale 1, 5

Critical Clinical Considerations

Combination therapy is essential: PRP combined with topical minoxidil 5% is significantly more effective than either PRP alone or minoxidil alone, and both monotherapies are superior to placebo 1, 2, 8

Avoid activation: Do not activate PRP before injection, as nonactivated PRP produces superior clinical outcomes 1, 2

Continuous treatment required: All benefits require ongoing maintenance therapy; discontinuation results in loss of gains 6

Best candidates: Mild to moderate androgenetic alopecia responds most favorably, with more severe grades showing variable results 1

Safety Profile

  • No remarkable adverse effects have been reported in clinical studies 3
  • The autologous nature of PRP makes it inherently safe with minimal risk of allergic reactions 5, 9
  • Pain during injection is the primary complaint, though PRP is generally better tolerated than some alternatives 1

Alternative Considerations

  • Platelet-rich fibrin (PRF) is emerging as a potentially superior alternative, offering theoretical advantages over PRP with similar efficacy and lower cost 1, 6
  • PRF can be administered as intradermal injections using the same three-session protocol 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Minoxidil Treatment for Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Platelet-rich plasma in androgenic alopecia: myth or an effective tool.

Journal of cutaneous and aesthetic surgery, 2014

Guideline

Hair Loss Treatment for Women Including Oral Minoxidil

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Platelet-Rich Plasma as a Treatment for Androgenetic Alopecia.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2019

Guideline

Minoxidil Treatment for Androgenetic Alopecia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Platelet-Rich Plasma for Hair Restoration.

Facial plastic surgery clinics of North America, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.